Both in vivo and in vitro results showed that upregulation of BACH2 significantly inhibited the development of cardiac hypertrophy, whereas BACH2 knockdown exacerbated the progression of cardiac hypertrophy. Here, BACH2 is linked to cardiac hypertrophy.